Viola Tricolor Whole

The dosage of Viola Tricolor Whole is highly individualized, particularly when used as an allergenic extract. There is no 'one-size-fits-all' dose, as the patient's sensitivity level dictates the starting point.

• Diagnostic Skin Testing: For prick testing, a concentration of 1:10 or 1:20 w/v is typically used. For intradermal testing, the extract is diluted significantly, often to 1:1,000 or 1:10,000 w/v, to prevent systemic reactions.
• Immunotherapy (Build-up Phase): Treatment usually begins with a very low dose (e.g., 0.05 mL of a 1:100,000 dilution) administered once or twice weekly. The dose is incrementally increased based on the patient's local reaction until the maintenance dose is reached.
• Immunotherapy (Maintenance Phase): The maintenance dose typically ranges from 0.2 mL to 0.5 mL of a 1:10 or 1:20 w/v concentration, administered every 2 to 4 weeks.
• Oral Botanical Use: If prescribed as a traditional tincture, the typical dose is 2–4 mL three times daily, though this is not standardized for allergy treatment.

Viola Tricolor Whole is generally not recommended for children under the age of 5 for immunotherapy due to the difficulty in communicating early symptoms of systemic reactions.

• Children 5-12 years: Dosage follows the same titration schedule as adults but may require slower escalation. The physician will monitor for growth parameters if the Adrenocorticotropic Hormone [EPC] effects are a concern, though this is rare at standard allergy doses.
• Adolescents: Standard adult dosing protocols are typically applied, adjusted for the patient's specific sensitivity.

Renal Impairment

No specific dosage adjustments are provided in the manufacturer's labeling for renal impairment. However, since metabolites are excreted renally, clinicians should monitor for increased sensitivity or side effects in patients with a GFR below 30 mL/min.

Hepatic Impairment

Caution is advised in patients with severe hepatic dysfunction, as the metabolism of the flavonoid and phenolic components may be delayed, potentially increasing the risk of systemic toxicity.

Elderly Patients

Geriatric patients may have a higher prevalence of cardiovascular disease, which increases the risk associated with epinephrine use if an allergic reaction occurs. Dosing should be conservative, and the 'build-up' phase may be extended.

• Administration: Injectable extracts must be administered subcutaneously, usually in the posterior aspect of the upper arm. It must NEVER be injected intravenously.
• Observation: Patients must remain in the medical office for at least 30 minutes following an injection to monitor for signs of anaphylaxis.
• Timing: Injections should be scheduled at the same time of day when possible. Avoid vigorous exercise for 2 hours before and after the injection, as increased circulation can accelerate allergen absorption and trigger a reaction.
• Storage: Store the extract in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the vial in the original carton to protect it from light.

If a dose is missed during the build-up phase, the next dose may need to be reduced to ensure safety. If a dose is missed during the maintenance phase by more than one week, your doctor may revert to a previous, lower dose. Do not double the dose to catch up.

An overdose of Viola Tricolor Whole extract typically manifests as a severe systemic allergic reaction.

• Symptoms: Hives (urticaria), swelling of the throat (angioedema), wheezing, rapid heart rate, or a sudden drop in blood pressure (shock).
• Emergency Measures: Immediate administration of epinephrine (0.3 mg for adults) is the primary treatment. Seek emergency medical attention (call 911) immediately if an overdose or systemic reaction is suspected.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or frequency without medical guidance, as this significantly increases the risk of a life-threatening reaction.

Most patients receiving Viola Tricolor Whole as an allergenic extract will experience local reactions at the site of administration. These are generally considered a normal part of the immune response.

• Local Erythema (Redness): Redness at the injection site that may appear within minutes and last for several hours.
• Local Edema (Swelling): A small 'wheal' or swelling, often described as feeling like a mosquito bite. If the swelling is larger than a half-dollar (approx. 3 cm), inform your doctor before the next dose.
• Pruritus (Itching): Intense itching at the site of injection or where the skin test was performed.
• Gastrointestinal Upset: When taken orally in botanical forms, mild nausea or stomach cramping may occur due to the saponin content.

• Fatigue: A feeling of tiredness or 'brain fog' following an injection, which may last for 24 hours.
• Headache: Mild to moderate tension-type headaches.
• Nasal Congestion: A temporary increase in allergic rhinitis symptoms shortly after administration.
• Urticaria (Hives): Scattered hives appearing on parts of the body other than the injection site.

• Lymphadenopathy: Swelling of the lymph nodes near the injection site (usually the axillary nodes).
• Persistent Skin Discoloration: A small area of hyperpigmentation or 'tattooing' at the site of repeated injections.
• Arthralgia: Mild joint pain or stiffness, possibly related to immune complex formation.

> Warning: Stop taking Viola Tricolor Whole and call your doctor immediately or seek emergency care if you experience any of the following:

• Anaphylaxis: A life-threatening systemic reaction. Symptoms include a feeling of impending doom, swelling of the tongue or throat, difficulty breathing, and a rapid, weak pulse.
• Angioedema: Deep swelling of the face, lips, or eyelids.
• Severe Bronchospasm: Sudden, severe wheezing or chest tightness that does not respond to a rescue inhaler.
• Hypotension: A sudden drop in blood pressure which may cause fainting, dizziness, or blurred vision.
• Generalized Seizures: Extremely rare, usually associated with severe hypoxia during a systemic reaction.

With prolonged use of Viola Tricolor Whole in immunotherapy, some patients may develop 'serum sickness-like' symptoms, characterized by fever, joint pain, and rashes. This is due to the chronic stimulation of the immune system. Additionally, because of its classification under Adrenocorticotropic Hormone [EPC], there is a theoretical (though clinically unverified at standard doses) risk of mild HPA axis suppression if extremely high doses are used over many years.

While Viola Tricolor Whole may not have a specific individual black box warning for the plant itself, all Non-Standardized Allergenic Extracts carry a general class warning regarding the risk of severe non-fatal and fatal systemic allergic reactions.

Summary of Warning: This product can cause severe life-threatening systemic reactions, including anaphylaxis. It should only be administered by physicians who are exceptionally experienced in the treatment of systemic allergic reactions and in facilities equipped with the necessary equipment and medication (including epinephrine) to treat such reactions. Patients with unstable asthma are at a higher risk for fatal reactions.

Report any unusual or persistent symptoms to your healthcare provider immediately. Documenting the size and duration of local reactions can help your doctor adjust your treatment plan safely.

Viola Tricolor Whole must be used with extreme caution. It is a biological product that directly interacts with the immune system. Patients must be fully aware that every dose carries a small but significant risk of a systemic allergic reaction. It is not a 'simple' herbal supplement when used in a clinical extract form.

No FDA black box warnings specifically for the name 'Viola Tricolor Whole' exist, but it falls under the mandatory class warning for Allergenic Extracts.

Class Warning Text: "Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis. Patients should be observed for at least 30 minutes after receiving an injection. Those with severe or unstable asthma are at increased risk for fatal reactions. Epinephrine must be available for immediate use."

• Allergic Reactions / Anaphylaxis: This is the primary risk. Anaphylaxis can occur even in patients who have previously tolerated the extract for years. Factors such as infection, menstruation, or changes in other medications can lower the 'allergic threshold.'
• Asthma Status: If you have asthma, it must be well-controlled before receiving an injection. If you are experiencing a 'flare-up' or your peak flow meter readings are low, you must skip your dose of Viola Tricolor Whole.
• Cardiovascular Disease: Patients with underlying heart conditions are at higher risk if they require epinephrine to treat an allergic reaction, as epinephrine increases heart rate and oxygen demand.
• Autoimmune Disorders: Use with caution in patients with active autoimmune diseases (e.g., Lupus, Rheumatoid Arthritis), as the immunomodulatory effects of the extract could theoretically exacerbate the condition.

• Peak Flow Monitoring: For asthmatic patients, peak flow should be checked before every injection.
• Injection Site Inspection: The doctor will measure any 'delayed' reactions (swelling that occurs 6-24 hours later) to determine if the dose should be increased or decreased.
• Vital Signs: Blood pressure and heart rate may be checked before and after the 30-minute observation period.

While Viola Tricolor Whole does not typically cause sedation, a systemic reaction or the subsequent administration of antihistamines/epinephrine can significantly impair your ability to drive. It is recommended to wait at least 30 minutes to ensure you feel stable before operating a vehicle.

Alcohol consumption should be avoided for several hours before and after an injection. Alcohol causes vasodilation (widening of blood vessels), which can speed up the absorption of the allergen and increase the risk of a systemic reaction.

If you decide to stop Viola Tricolor Whole immunotherapy, you can typically do so without a tapering period. However, the 'allergic protection' provided by the extract will gradually fade over several months. If you stop for a period and then wish to restart, you MUST start back at the lowest possible dose to avoid anaphylaxis.

> Important: Discuss all your medical conditions, especially respiratory and heart problems, with your healthcare provider before starting Viola Tricolor Whole.

• Beta-Blockers (e.g., Propranolol, Atenolol): These medications are strictly contraindicated for patients receiving allergenic extracts. If you have an allergic reaction, beta-blockers will prevent epinephrine from working effectively, making a life-threatening reaction much harder to treat.
• MAO Inhibitors (e.g., Phenelzine): These can potentiate the effect of epinephrine, leading to dangerously high blood pressure if an allergic reaction needs to be treated.

• ACE Inhibitors (e.g., Lisinopril): Some studies suggest that ACE inhibitors may increase the risk of severe systemic reactions to immunotherapy or make the reactions more difficult to manage.
• Immunosuppressants (e.g., Cyclosporine, Prednisone): These drugs may reduce the effectiveness of Viola Tricolor Whole by suppressing the immune system's ability to develop the desired tolerance.
• Tricyclic Antidepressants (e.g., Amitriptyline): Similar to MAOIs, these can interfere with the body's response to emergency medications used during an allergic reaction.

• Antihistamines (e.g., Loratadine, Cetirizine): While often used to manage minor side effects, regular use of antihistamines can mask the early warning signs of a systemic reaction (like itching or mild hives), potentially leading to a delay in recognizing a more serious problem.
• Other Allergenic Extracts: If you are receiving multiple types of immunotherapy (e.g., for grass, dust mites, and Viola), the cumulative 'allergic load' increases the risk of a reaction.

• High-Fat Meals: May slightly delay the absorption of oral Viola Tricolor components but do not significantly impact the injectable extract.
• Cross-Reactive Foods: Patients allergic to Viola Tricolor may experience 'Oral Allergy Syndrome' when eating related plants or certain fruits. Discuss any food-related mouth itching with your allergist.

• St. John's Wort: May induce CYP enzymes, potentially altering the metabolism of the flavonoid components of Viola Tricolor.
• Echinacea: As an immune stimulant, it may counteract the 'tolerance-building' goal of Viola Tricolor immunotherapy.

• Skin Testing: Viola Tricolor Whole will obviously interfere with future allergy skin tests for the same or related species.
• Urinary Salicylates: Due to the salicylic acid content in the plant, high doses of the oral extract may cause a false positive on certain salicylate screens.

For each major interaction, the mechanism typically involves either pharmacodynamic interference (preventing emergency drugs from working) or immunological synergy (increasing the risk of a cytokine storm or anaphylaxis).

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially if you have been prescribed a new heart or blood pressure medication.

Viola Tricolor Whole must NEVER be used in the following circumstances:

1. 1Uncontrolled Asthma: Patients with an FEV1 (Forced Expiratory Volume) consistently below 70% of predicted values are at an unacceptably high risk of fatal bronchospasm during a systemic reaction.
2. 2Recent Myocardial Infarction (Heart Attack): Within the last 3-6 months. The risk of using epinephrine during a reaction outweighs the benefits of the extract.
3. 3History of Severe Anaphylaxis to Viola Tricolor: If a patient has already experienced a Grade 4 systemic reaction (cardiac arrest or respiratory failure) to this specific extract, the risk of re-exposure is too high.
4. 4Beta-Blocker Therapy: As mentioned in the interactions section, the inability to respond to epinephrine is an absolute contraindication for elective immunotherapy.

Conditions requiring a careful risk-benefit analysis by a specialist:

• Pregnancy: While not strictly contraindicated if the patient is already on a stable maintenance dose, starting new immunotherapy during pregnancy is avoided due to the risk of fetal hypoxia during a systemic reaction.
• Autoimmune Disease in Remission: The potential for the extract to 're-awaken' the immune system must be weighed against the severity of the patient's allergies.
• Malnutrition or Severe Debility: The patient may not have the physiological reserve to survive a systemic reaction.

Patients who are allergic to other members of the Violaceae family may experience cross-allergic reactions. There is also a known cross-reactivity between Viola species and certain salicylates. If you have a known 'Aspirin Triad' (aspirin sensitivity, nasal polyps, and asthma), use Viola Tricolor Whole with extreme caution.

> Important: Your healthcare provider will evaluate your complete medical history, including a physical exam and lung function tests, before prescribing Viola Tricolor Whole.

FDA Pregnancy Category: Not formally assigned (typically treated as Category C).

There are no adequate and well-controlled studies of Viola Tricolor Whole in pregnant women. Animal reproduction studies have not been conducted.

• First Trimester: Starting immunotherapy is generally avoided to prevent any potential interference with organogenesis if a systemic reaction occurs.
• Second and Third Trimesters: If a woman is already on a maintenance dose and is tolerating it well, the doctor may choose to continue the dose or reduce it by 50% to maintain safety. The primary risk to the fetus is maternal anaphylaxis, which can lead to uterine contractions and fetal hypoxia (lack of oxygen).

It is not known whether the components of Viola Tricolor Whole are excreted in human milk. Because many drugs and proteins are excreted in milk, caution should be exercised. However, since the allergens are proteins that would likely be digested in the infant's stomach, the risk is generally considered low. The mother should be monitored for any signs that the infant is developing a new allergy or rash.

• Safety and Effectiveness: Not established in children under 5 years of age.
• Considerations: Children may not be able to articulate the early symptoms of a reaction (e.g., an 'itchy throat' or 'funny feeling' in the chest). Close observation by a pediatric allergist is mandatory.
• Growth: Due to the Adrenocorticotropic Hormone [EPC] classification, there is a theoretical concern regarding growth if used in extremely high doses, though this has not been observed in standard clinical practice.

Clinical studies of Viola Tricolor Whole did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.

• Risk Factors: Older patients are more likely to have co-morbidities like hypertension or coronary artery disease, making them poor candidates for epinephrine if a reaction occurs.
• Dosing: Start at the lowest possible dose and increase with caution.

In patients with chronic kidney disease (CKD), the clearance of the small-molecule bioactive components (flavonoids, salicylates) may be reduced. While the protein allergens are not cleared by the kidneys, the systemic 'inflammatory load' should be monitored. No specific GFR-based adjustments are published, but clinical vigilance is required.

Patients with Child-Pugh Class B or C cirrhosis may have altered protein synthesis and metabolism. This could theoretically affect how the body processes the immunomodulatory cyclotides. Use with caution and monitor for signs of systemic toxicity.

> Important: Special populations require individualized medical assessment and often a slower titration of the medication.

Viola Tricolor Whole functions as a biological response modifier. The primary active constituents are cyclotides, specifically kalata-type peptides. These peptides possess a unique cyclic cystine knot (CCK) motif, which provides extraordinary stability against thermal, chemical, and enzymatic degradation.

In the immune system, these cyclotides interact with the phospholipid bilayer of T-lymphocytes. Research indicates they can inhibit the proliferation of activated T-cells by interfering with IL-2 expression. This suppresses the overactive Th2 immune response characteristic of allergic disease. Simultaneously, the extract provides a controlled 'antigenic challenge' that re-trains B-cells to produce IgG4 instead of IgE.

• Onset of Action: For diagnostic testing, the onset is rapid (15–30 minutes). For immunotherapy, the onset of clinical desensitization takes 3–6 months of regular injections.
• Duration of Effect: A single injection's immunological 'signal' lasts for days, but the cumulative effect of a maintenance course can last for years after treatment is discontinued.
• Tolerance: Unlike many drugs, 'tolerance' in this context is the desired therapeutic goal (immunological desensitization) rather than a loss of drug effect.

| Parameter | Value |

|---|---|

| Bioavailability | Low (Oral) / High (Subcutaneous) |

| Protein Binding | Variable (approx. 60-80% for flavonoids) |

| Half-life | 4–12 hours (small molecules); Weeks (immunological) |

| Tmax | 1–2 hours (phenolics); 30 mins (local allergen) |

| Metabolism | Hepatic (Phase II conjugation) |

| Excretion | Renal (Primary) |

• Molecular Components: Complex mixture of proteins (allergens), cyclotides (e.g., Varv A, Varv B), flavonoids (rutin, violanthin), and salicylic acid.
• Solubility: The extract is typically prepared in a saline-glycerin solution to maintain protein stability.
• Drug Class: Non-Standardized Food Allergenic Extract; Adrenocorticotropic Hormone-related botanical.

Viola Tricolor Whole is part of the Allergenic Extracts therapeutic class. It is grouped with other non-standardized extracts like dandelion or ragweed (non-standardized versions). Its secondary classification as an Adrenocorticotropic Hormone [EPC] relates to its potential to influence the endocrine system, though this is less common in modern Western clinical practice than its use in allergy.